MANNKIND CORP (MNKD:NASDAQ)
$4.09 -0.07 (-1.6827%)
Analysed MANNKIND CORP (MNKD:NASDAQ) News Sources
MannKind (MNKD) Stock Looks Undervalued On Cash Flow Yet Mixed On Broader Checks
25-07-2026
yahoo.com
MannKind (MNKD) Following Furoscix Approval, Buying Opportunity Or Already Priced In?
25-07-2026
yahoo.com
FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease
27-07-2026
yahoo.com
MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
29-07-2026
yahoo.com
MannKind’s Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway
29-07-2026
marketbeat.com
MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update
05-08-2026
yahoo.com
MannKind (MNKD) Reports Q2 Loss, Beats Revenue Estimates
05-08-2026
yahoo.com
Compared to Estimates, MannKind (MNKD) Q2 Earnings: A Look at Key Metrics
05-08-2026
yahoo.com
MannKind Q2 Earnings Call Highlights
06-08-2026
marketbeat.com
MannKind's Diversified Portfolio Seen Leading to Higher Revenue in H2, Wedbush Says
06-08-2026
yahoo.com
What is the current price of MANNKIND CORP (MNKD:NASDAQ)?
The current price of MANNKIND CORP (MNKD:NASDAQ) is $4.09.
MANNKIND CORP (MNKD:NASDAQ) absolute price change since previous trading day?
The absolute price change of MANNKIND CORP (MNKD:NASDAQ) since the previous trading day is $-0.07.
MANNKIND CORP (MNKD:NASDAQ) percentage price change since previous trading day?
The percentage price change of MANNKIND CORP (MNKD:NASDAQ) since the previous trading day is -1.6827%.
What is the most recent average sentiment score for MANNKIND CORP (MNKD:NASDAQ)?
The most recent average sentiment score for MANNKIND CORP (MNKD:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for MANNKIND CORP (MNKD:NASDAQ)?
The most recent sentiment for MANNKIND CORP (MNKD:NASDAQ) is .
SEC-8K** Filing Available For MANNKIND CORP (MNKD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.